Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Total Non-Current Liabilities (2020)

Historic Total Non-Current Liabilities for Tango Therapeutics (TNGX) over the last 1 years, with Q4 2020 value amounting to $168.6 million.

  • Tango Therapeutics' Total Non-Current Liabilities changed N/A to $168.6 million in Q4 2020 from the same period last year, while for Dec 2020 it was $168.6 million, marking a year-over-year change of. This contributed to the annual value of $168.6 million for FY2020, which is N/A changed from last year.
  • Tango Therapeutics' Total Non-Current Liabilities amounted to $168.6 million in Q4 2020.
  • In the past 5 years, Tango Therapeutics' Total Non-Current Liabilities ranged from a high of $168.6 million in Q4 2020 and a low of $168.6 million during Q4 2020